E. Pyott David - Jun 5, 2025 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Director
Signature
/s/ Jennifer Woo, attorney-in-fact
Stock symbol
PLRX
Transactions as of
Jun 5, 2025
Transactions value $
$0
Form type
4
Date filed
6/9/2025, 08:43 PM
Previous filing
May 12, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PYOTT DAVID E I Director C/O PLIANT THERAPEUTICS, INC., 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO /s/ Jennifer Woo, attorney-in-fact 2025-06-09 0001051578

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option vest and become exercisable on October 1, 2025, January 1, 2026, and April 1, 2026, respectively, and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 5, 2025 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting.